文献速递脊柱关节炎

银屑病关节炎患者与医生感知的缓解及低疾病活动度比较:14国410例分析

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries.
PubMed 文献 · Ann Rheum Dis · 2018-11-15

本研究基于ReFlap研究(NCT03119805),纳入14国410例病程>2年的银屑病关节炎成人患者,横断面比较基于患者和医生视角的多种缓解与低疾病活动度(LDA)定义。结果显示缓解/LDA达成率较高,患者感知缓解/LDA达65.4%;VLDA/MDA较DAPSA定义更严格,DAPSA定义检测患者定义缓解/LDA的敏感性优于VLDA/MDA。

要点

  • 患者感知缓解/LDA频繁(65.4%),医生感知为67.6%但与其他定义一致性差。
  • VLDA/MDA比DAPSA缓解/LDA更严格,DAPSA定义敏感性更高。
  • 患者感知与复合评分一致性为中等至良好(kappa 0.12-0.65)。

核心结论

  • 在该未选择人群中,缓解/LDA频繁达成,VLDA/MDA是比DAPSA定义更严格的缓解/LDA标准。
  • DAPSA定义的缓解/LDA在检测患者定义的缓解/LDA方面优于VLDA/MDA。
  • 医生感知的单问题缓解/LDA频繁但与其他定义表现差,需进一步研究长期结局。

研究设计与样本

  • ReFlap(Remission/Flare in PsA;NCT03119805)横断面分析,纳入14国410例医生确认的银屑病关节炎成人患者,病程>2年。

主要发现

  • 410例患者平均年龄53.9(12.5)岁,50.7%为男性,病程11.2(8.2)年,56.8%使用生物制剂。
  • 缓解频率从12.4%(VLDA)至36.1%(医生感知缓解),LDA频率从25.4%(MDA)至43.9%(患者感知LDA)。
  • 患者感知缓解/LDA频率为65.4%,医生感知缓解/LDA频率为67.6%。
  • 患者感知与复合评分间一致性为中等至良好(kappa范围0.12-0.65)。
  • 以患者感知缓解/LDA为参照,DAPSA定义缓解/LDA敏感性73.1%、特异性76.8%;VLDA/MDA敏感性51.5%、特异性88.0%。

关键数值与推荐

  • 缓解定义包括VLDA、DAPSA≤4、医生感知缓解和患者感知缓解(特定问题是/否)。
  • LDA定义包括MDA、DAPSA<14、医生感知LDA和患者感知LDA。
  • DAPSA定义缓解/LDA检测患者定义缓解/LDA的敏感性73.1%、特异性76.8%。
  • VLDA/MDA检测患者定义缓解/LDA的敏感性51.5%、特异性88.0%。

临床怎么用

  • 临床评估银屑病关节炎缓解/LDA时,应认识到患者感知与医生感知及复合评分间存在差异。
  • DAPSA定义可能更适用于识别患者认为的缓解/LDA,而VLDA/MDA更严格。
  • 单问题医生感知缓解/LDA不宜替代复合评分进行疾病状态评估。

局限性

  • 横断面设计无法评估长期结局。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective was to compare different definitions of remission and low disease activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients' and physicians' perspectives. METHODS: In ReFlap (Remission/Flare in PsA; NCT03119805), adults with physician-confirmed PsA and >2 years of disease duration in 14 countries were included. Remission was defined as very low disease activity (VLDA), Disease Activity index for PSoriatic Arthritis (DAPSA) ≤4, and physician-perceived and patient-perceived remission (specific question yes/no), and LDA as minimal disease activity (MDA), DAPSA <14, and physician-perceived and patient-perceived LDA. Frequencies of these definitions, their agreement (prevalence-adjusted kappa), and sensitivity and specificity versus patient-defined status were assessed cross-sectionally. RESULTS: Of 410 patients, the mean age (SD) was 53.9 (12.5) years, 50.7% were male, disease duration was 11.2 (8.2) years, 56.8% were on biologics, and remission/LDA was frequently attained: respectively, for remission from 12.4% (VLDA) to 36.1% (physician-perceived remission), and for LDA from 25.4% (MDA) to 43.9% (patient-perceived LDA). Thus, patient-perceived remission/LDA was frequent (65.4%). Agreement between patient-perceived remission/LDA and composite scores was moderate to good (kappa range, 0.12-0.65). When patient-perceived remission or LDA status is used as reference, DAPSA-defined remission/LDA and VLDA/MDA had a sensitivity of 73.1% and 51.5%, respectively, and a specificity of 76.8% and 88.0%, respectively. Physician-perceived remission/LDA using a single question was frequent (67.6%) but performed poorly against other definitions. CONCLUSION: In this unselected population, remission/LDA was frequently attained. VLDA/MDA was a more stringent definition than DAPSA-based remission/LDA. DAPSA-based remission/LDA performed better than VLDA/MDA to detect patient-defined remission or remission/LDA. Further studies of long-term outcomes are needed.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Gorlier C, Orbai AM, Puyraimond-Zemmour D, et al. Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries. Ann Rheum Dis. 2018. PMID: 30442648. doi:10.1136/annrheumdis-2018-214140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。